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Emerging contaminants have commonly been observed in environmental waters but have not been
included in water quality assessments at many locations around the world. To evaluate the availability of
reclaimed water in Kinmen, Taiwan, this study provides the ﬁrst survey of the distribution of thirty-three
pharmaceuticals and ﬁve perﬂuorinated chemicals in lake waters and water from local wastewater
treatment plants (WWTPs). The results showed that the target emerging contaminants in Kinmen lakes
were at trace ng/L concentrations. In addition, most of the target compounds were present in the Jin-
cheng and Taihu WWTP inﬂuents at ng/L concentrations levels, of which 5 compounds (erythromycin-
H2O (1340 ng/L), ibuprofen (1763 ng/L), atenolol (1634 ng/L), acetaminophen (2143 ng/L), and caffeine
(3113 ng/L)) reached mg/L concentrations. The overall treatment efﬁciencies of the Jincheng and Taihu
WWTPs with respect to these pharmaceuticals and perﬂuorinated chemicals were poor; half of the
compounds were less than 50% removed. Five compounds (sulfamethoxazole, erythromycin-H2O, clar-
ithromycin, ciproﬂoxacin and oﬂoxacin) with risk quotient (RQ) values > 1 in the efﬂuent should be
further investigated to understand their effects on the aquatic environment. Additional and advanced
treatment units are found necessary to provide high-quality recycled water and sustainable water
resources.
Copyright © 2016, The Authors. Production and hosting by Elsevier B.V. on behalf of KeAi
Communications Co., Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Kinmen, an outlying subtropical island of Taiwan (24゜300N,
118゜250E), is located on the west side of the Taiwan Strait. Kinmen
covers a total area of 153.1 km2 and has a total population of
approximately 120,000 (http://www.kinmen.gov.tw/). The eco-
nomic structure of Kinmen is dominated by agriculture, and the
consumption of water for irrigation is approximately 9000 tons/
day. Kaoliang Liquor is an economic mainstay of Kinmen and has
resulted in agriculture and tourism development.
Water scarcity is a severe and urgent issue in Kinmen. Because
urbanization has occurred rapidly in Kinmen in recent years, water
consumption in Kinmen has increased. However, only a limited).
nications Co., Ltd.
and hosting by Elsevier B.V. on be
y-nc-nd/4.0/).number of short and small rivers and streams exist in Kinmen, with
rainfall mainly occurring fromApril to September. Furthermore, the
annual evaporation (1684 mm/yr) is greater than the annual rain-
fall (1047 mm/yr) in Kinmen, which results in water shortages.
Although several lakes and reservoirs are located in Kinmen, severe
algal blooms and eutrophication have resulted in their poor water
quality. Groundwater has played an important role in supplying a
sufﬁcient amount of water with up to 54% of water for domestic
use, agricultural irrigation and industrial use (e.g., Kaoliang Liquor
manufacturing process) obtained from groundwater sources.
Accordingly, continuous and excessive groundwater pumping has
led to decreased groundwater levels (a decrease of nearly 20 cm/yr)
and groundwater salinization. To solve the urgent water scarcity
problem, a project for the development of reclaimed water and
alternative water sources in Kinmen has been implemented.
Currently, treated water in Kinmen is recovered for non-potable
reuse, such as agricultural irrigation and groundwater recharge,
following conventional wastewater treatment processes. To
improve the use and application of reclaimed water, emerginghalf of KeAi Communications Co., Ltd. This is an open access article under the CC BY-
W.W.-P. Lai et al. / Emerging Contaminants 2 (2016) 135e144136contaminants must remain part of the discussion because many
emerging contaminants are not completely removed by conven-
tional wastewater treatment processes and are, consequently,
released into receiving aquatic environments and potentially
threaten the ecosystem and human health [1e4].
Pharmaceuticals and personal care products (PPCPs), hormones
and industrial compounds, such as perﬂuorinated compounds
(PFCs), were the most commonly detected emerging contaminants.
These compounds have been found at ng/L to mg/L concentrations
around the world in many types of water matrices, including
wastewater treatment plant (WWTP) inﬂuents and efﬂuents, hos-
pital wastewater, wastewater from pharmaceutical manufacturing
companies, industrial wastewater and even surface water and
groundwater. For example, nonsteroidal anti-inﬂammatory drugs
(NSAIDs), antibiotics and other pharmaceuticals have commonly
been detected in hospital wastewater and pharmaceutical
manufacturing wastewater in Korea, Switzerland and the USA
[5e7], with corresponding concentrations of up to mg/L. Regarding
the removal efﬁciency of pharmaceuticals in WWTPs, Canadian
researchers have indicated that many compounds are not effec-
tively removed (e.g., diclofenac and gemﬁbrozil) and remain in
efﬂuents [8]. In addition, Spanish researchers have demonstrated
that the removal efﬁciency of different pharmaceuticals varies
greatly (6e93%) and differs among WWTPs [9]. In a nationwide
reconnaissance conducted by the US Geological Survey [10], 95
pharmaceuticals, hormones, and other organic wastewater con-
taminants were investigated in 139 streams in the USA. The results
of the reconnaissance indicated that many compounds may survive
wastewater treatment processes and enter streams. A study from
the UK [11] showed the frequent presence of low concentrations of
pharmaceuticals in rivers (the most frequently detected com-
pounds include erythromycin-H2O, acetaminophen, trimethoprim,
naproxen and ibuprofen). These pharmaceutical compounds have
also been detected in groundwater [12]. In addition to pharma-
ceuticals, PFCs have generally been recognized as recalcitrant
compounds, being detected in industrial wastewaters and their
receiving water bodies in many countries (e.g., Japan, China,
Thailand, Spain, Taiwan and Germany) [13e17]. In Taiwan, our
previous work has demonstrated the occurrence of these emerging
contaminants in many types of water matrices (e.g., WWTP
wastewater, hospital wastewater, industrial wastewater, surface
water and groundwater) [16e21]. Based on previous work, 38 of
the most commonly occurring pharmaceuticals (including antibi-
otics, NSAIDs, lipid regulators, cholesterol lowering drugs, b-
blockers, vasodilators, psychiatric drugs and psychostimulants) and
PFCs were chosen as our target compounds andmonitored for their
occurrence on Kinmen Island.
The objectives of this study are to (i) simultaneously analyze 38
emerging contaminants using solid-phase extraction (SPE) com-
bined with liquid chromatographyetandem mass spectrometry;
(ii) investigate the occurrence of the target compounds in Taihu and
Lunghu Lakes (the main drinking water sources for Kinmen resi-
dents); and (iii) investigate the occurrence and removal of the
target compounds at the Jincheng and Taihu WWTPs (the largest
and second largest WWTPs in Kinmen) and evaluate the use of the
treated discharge water as reclaimed water regarding the target
emerging contaminants. Because water scarcity is an urgent
problem in Kinmen, this study could be used by the Kinmen gov-
ernment to assist in the establishment of guidelines (e.g., evalua-
tion of the availability of reclaimed water in Kinmen and the
development of related reclaimed water policies in the future). To
our knowledge, this is the ﬁrst study of the distribution of emerging
contaminants in the water matrices of Kinmen Island. The experi-
ence at Kinmen Island can be used as an example for islands that
are similar and in need of reclaimed waters around the world.2. Materials and methods
2.1. Sample collection, pretreatment and analysis
The sampling sites, including two lakes (Taihu Lake and Lunghu
Lake) and two WWTPs (Jincheng WWTP and Taihu WWTP), are
shown in Fig. 1. Water samples were collected as grab samples.
Although the grab sample method can result in large uncertainties
(because it involves sampling water at one point in time), the
samples were collected based on the hydraulic retention times of
the two WWTPs to minimize these uncertainties. In addition, all of
the samples were collected during the daytime. Triplicate samples
were collected and stored in 1-L amber glass bottles in ice-packed
containers. All sample bottles (except those used for PFC analysis)
contained 4 mL 0.125 M EDTA-2Na/L before sample collection. The
samples were vacuum-ﬁltered through 0.45 and 0.22 mm disk ﬁlter
paper (ADVANTEC, Toyo Roshi Kaisha, Ltd., Japan), acidiﬁed to pH 4
using hydrochloric acid and stored at 4 C until solid-phase
extraction (SPE).
The samples were analyzed using SPE combined with liquid
chromatographyetandem mass spectroscopy (LCeMS/MS). To
obtain the most linear range and the best analytical signals with
LCeMS/MS, the target compounds were classiﬁed into the
following four categories: Group 1: sulfonamide antibiotics (sulfa-
diazine, sulfamethoxazole, sulfathiazole, sulfamethazine, sulfamo-
nomethoxine and sulfadimethoxine), macrolide antibiotics
(erythromycin-H2O, clarithromycin, roxithromycin and tylosin),
imidazole antibiotics (dimetridazole and metronidazole), quino-
lone antibiotics (nalidixic acid, ﬂumequine, pipemidic acid, nor-
ﬂoxacin, ciproﬂoxacin and oﬂoxacin), non-steroidal anti-
inﬂammatory drugs (acetaminophen), other antibiotics (trimetho-
prim), vasodilator (pentoxifylline), psychiatric drugs (carbamaze-
pine) and psychostimulants (caffeine); Group 2: non-steroidal anti-
inﬂammatory drugs (ibuprofen, naproxen and ketoprofen), lipid
regulators and cholesterol-lowering drugs (cloﬁbric acid, gemﬁ-
brozil and bezaﬁbrate); Group 3: b-blockers (propranolol, atenolol,
metoprolol and sotalol); and Group 4: perﬂuoroalkyl sulfonic acids
(PFOS) and perﬂuorinated carboxylic acids (PFHxA, PFOA, PFDA and
PFHpA). Based on the physicochemical properties and extraction
efﬁciencies of the four groups, Oasis MCX cartridges (Waters, Mil-
ford, MA, USA) were utilized for negative-mode analytes, and Oasis
HLB cartridges (Waters, Milford, MA, USA) were utilized for posi-
tive- and negative-mode analytes. The different target compound
classes were extracted using the following three SPE methods.
2.1.1. Method 1 (for groups 1 and 2)
The HLB cartridges were preconditioned using 6mL of methanol
and 6 mL of DI water (pH ¼ 4.0). Aliquots from 400 mL water
samples (the pH was adjusted to 4.0 with hydrochloric acid) were
spiked with 40 mL of an internal standard (1 mg/L of 13C6-sulfa-
methazine, metronidazole-13C2, 15N2, ciproﬂoxacin-d8, eryth-
romycin-13C,d3 and roxithromycin-d7) and loaded into the
cartridges at a ﬂow rate of 3e6 mL/min. After sample passage, the
cartridges were rinsed with 6 mL of DI water (pH ¼ 4.0) and
drained, and after drainage, the analytes were eluted with 3 mL of
methanol and 3 mL of a 50% methanol-diethylether (v:v ¼ 50:50)
mixture. The eluents were collected, evaporated under a stream
nitrogen and reconstituted to a volume of 0.4 mL with 25% aqueous
methanol. The ﬁnal solutions were passed through a 0.45-mm PVDF
ﬁlter membrane prior to LCeMS/MS analysis.
2.1.2. Method 2 (for group 3)
TheMCX cartridges were preconditionedwith 6mL of methanol
and 6 mL of DI water (pH ¼ 4.0). Aliquots from 200 mL water
samples (the pH was adjusted to 4.0 using hydrochloric acid) were
Fig. 1. Map of the sampling sites (WWTPs: Jincheng WWTP and Taihu WWTP; lakes: Taihu Lake and Lunghu Lake) and the potential contamination sources.
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loaded into the cartridges at a ﬂow rate of 3e6 mL/min. Following
sample passage, the cartridges were rinsed with 6 mL of DI water
(pH ¼ 4.0) and drained. After draining, the analytes were eluted
with 6 mL of a mixture of 5% ammonium hydroxide in methanol
(v:v¼ 5:95). The eluents were collected, evaporated until dry under
a stream of nitrogen and reconstituted to 0.4 mL with 25% aqueous
methanol. The ﬁnal solutions were passed through a 0.45-mm PVDF
ﬁlter membrane prior to LCeMS/MS analysis.
2.1.3. Method 3 (for group 4)
The HLB cartridges were preconditioned with 6 mL of methanol
and 6 mL of DI water. Aliquots from 400 mL water samples were
spiked with 40 mL of an internal standard (10 mg/L13C8-PFOA) and
loaded into the cartridges at a ﬂow rate of 3e6 mL/min. After
sample passage, the cartridges were rinsed with 6 mL of DI water
and drained. After draining, the analytes were eluted with 6 mL
methanol. The eluents were collected, evaporated under a stream
of nitrogen and reconstituted to a volume of 0.4 mL with 50%
aqueous methanol. The ﬁnal solutions were passed through a 0.45-
mm PVDF ﬁlter membrane prior to LCeMS/MS analysis.
Samples were concentrated 500 times by SPE on an Oasis MCX
cartridge for positive-mode analytes and 1000 times on an Oasis
HLB cartridge for negative- and positive-mode analytes. All ex-
tractions were completed within 24 h of sample collection.
Chromatographic separations were performed in gradient
mode. Groups 1, 2 and 3 used 0.1% formic acid in DI water (mobile
phase A) and 0.1% formic acid in methanol (mobile phase B); and
Group 4 used 1 mM ammonium acetate in DI water (mobile phase
A) and 1 mM ammonium acetate in methanol (mobile phase B).
Twenty-seven target compounds (positive mode) and eleven target
compounds (negative mode) were separated by LCeMS/MS using
run times of 15 min and 7 min, respectively (Table S1).
Quantiﬁcation was performed using the internal standard
method and the multiple reaction monitoring (MRM) mode of a
Sciex API 4000 liquid chromatography mass spectrometry system
(Applied Biosystems, Foster City, CA) with positive and negative
electrospray ionization (ESI). Table S2 shows the internal standards
of the investigated compounds and their LCeMS/MS parameters.
The target compounds of Groups 1 and 3 were ionized in ESI pos-
itive mode, forming [MþH]þ ions. The target compounds of Groups
2 and 4 were ionized in ESI negative mode, forming [MH] ions.
The MS/MS fragmentation conditions were investigated, and the
collision energies were optimized for each individual compound toobtain the optimal response (Table S3). The best resolutions for the
optimal separations in this study were obtained using a ZORBAX
Eclipse XDB-C18 column (150  4.6 mm, 5 mm). The linearity of the
calibration curves was estimated by linear-mode least-squares
regression analysis (y ¼ aþ bx). The method detection limits
(MDLs) were determined from the minimum concentration of an-
alyte in the linear range with a signal-to-noise ratio of 10:1.
3. Results and discussion
In this study, we sampled two lakes (Taihu Lake and Lunghu
Lake) and two WWTPs (Jincheng WWTP and Taihu WWTP).
Because Taihu Lake and Lunghu Lake are the main sources of
drinking water in Kinmen, we sampled the water from these two
lakes to understand the distribution of the target emerging con-
taminants. Table 1 shows the characteristics (water sources, usage,
storage capacity and watershed area) of these two lakes. Regarding
the two WWTPs, the treated water in the Jincheng and Taihu
WWTPs is generally used for non-potable reuse purposes, such as
groundwater recharge and agricultural and landscape irrigation.
The presence of emerging contaminants is one critical aspect that
must be considered when evaluating the potential uses of recycled
water. Detailed information regarding the treatment processes,
type of treated water, hydraulic retention time, daily ﬂow and
receiving water bodies is provided in Table 2. For the Jincheng
WWTP, the two sampling timeswere in June 2013 and June 2014. At
the ﬁrst sampling time, the inﬂuent and the efﬂuent of the Jincheng
WWTP were sampled, and the overall removal efﬁciencies were
calculated. At the second sampling time, we investigated the
overall removal efﬁciencies and the efﬁciencies of the primary and
secondary treatment processes.
3.1. Occurrence of pharmaceuticals and PFCs in the lakes (Taihu
Lake and Lunghu Lake) in Kinmen
Prior to sample analysis, method validation was performed.
Recovery experiments were performed using DI water spiked with
the target analytes (Group 1, Group 2 and Group 3: 50 ng/L; Group
4: 25 ng/L) to estimate the percent recovery. The recoveries,
method detection limits (MDLs) and linearity (regression coefﬁ-
cient) of the investigated emerging contaminants are shown in
Table S4. The accuracy and precision were determined from tripli-
cate sample analyses and standard solutions of the target com-
pounds. The standard calibration curves of the target compounds
Table 1
Characteristics of the investigated lakes.
Lake Water sources Usage Storage capacity (m3) Watershed area (ha)
Taihu Lake Rainwater, surface runoff Drinking water 1,625,000 741
Lunghu Lake 452,000 220
Table 2
Characteristics of the investigated wastewater treatment plants.
WWTP Services Type of treated
water
Primary treatment
process
Secondary treatment
process
Disinfection
method
Hydraulic retention
time (hr)
Daily ﬂow
(CMD)
Receiving water
bodies
Jincheng
WWTP
Jincheng Township,
Jinning Township
Domestic
Industrial
Livestock
Hospital
efﬂuent
Screening þ Grit
chamber
Oxidation
ditch þ Sedimentation
Chlorination 20 4500 Taiwan Strait
Taihu
WWTP
Jinhu Township, Jinsha
Township
32 1500
W.W.-P. Lai et al. / Emerging Contaminants 2 (2016) 135e144138with internal standards were made using ten data points, and the
standards had concentrations of 0.5e500 mg/L. The standard cali-
bration curves of the target compounds without internal standards
were created using seven data points from 5 to 1000 mg/L. The re-
coveries were 67e118%, with relative standard deviation (RSD)
values ranging from 1 to 17% for the different target compounds in
DI water, except for gemﬁbrozil (133.7%). The MDLs ranged from
0.05 to 5 ng/L, with linearity >0.9953.
Table 3 shows the occurrence of 38 emerging contaminants in
Taihu Lake and Lunghu Lake. The results indicated that the con-
centrations of the target emerging contaminants in the two lakes
were at the trace ng/L level. For Taihu Lake, the concentrations of
every detected compound except caffeine (101.2 ng/L) were less
than 50 ng/L. The observed concentrations of the emerging con-
taminants in Lunghu Lake were also at the trace level, with the
concentrations of the detected compounds falling between 0.4 and
16.8 ng/L. Due to difﬁculties inmonitoring and controlling pollution
sources (e.g., pollution of domestic wastewater or livestock in-
dustries wastewater) in Kinmen lakes, these results can be used to
indicate the contamination levels of the drinking water sources
because these two lakes are the main sources of tap water for the
residents of Kinmen. Long-term and continuous monitoring of the
distribution of the target emerging contaminants in Kinmen lakes
is recommended.
3.2. Occurrence and removal of pharmaceuticals and PFCs in the
WWTPs (Jincheng WWTP and Taihu WWTP) in Kinmen
Table 4 shows the occurrence and removal of 38 emerging
contaminants in the Jincheng WWTP. These two WWTPs are
located near hospitals, livestock industries and factories, which
are considered to be potential contamination sources of emerging
contaminants [20,22,23]. In the following paragraphs, we discuss
the results obtained from the Jincheng WWTP in detail because
the Jincheng WWTP is the largest WWTP in Kinmen and can
represent the other WWTPs in Kinmen. Among the 38 target
compounds, 34 compounds from various classes were detected in
the Jincheng WWTP inﬂuent. Most of the compounds existed at
ng/L concentrations, whereas 4 pharmaceuticals were observed at
signiﬁcant concentrations (mg/L levels), including ibuprofen
(1260 ng/L), atenolol (1634 ng/L), acetaminophen (1950 ng/L), and
caffeine (2975 ng/L). Other studies have also noted that these four
compounds exist at higher concentrations in WWTP inﬂuents in
various countries [24]. In addition, all these pharmaceuticals
belong to humanmedicines, suggesting that the primary source ofpollution was human activities (e.g., from hospital wastewaters or
domestic wastewaters). Additional detailed investigations are
needed to conﬁrm the exact sources of pollution. Compared with
the emerging contaminant distributions in Taihu Lake and Lunghu
Lake, the concentrations of the contaminants in the two WWTPs
were signiﬁcantly higher, potentially because the sources of water
for the two lakes (Taihu Lake and Lunghu Lake) and the two
WWTPs (Jincheng WWTP and Taihu WWTP) were different. The
lake water was mainly replenished by rainwater and surface
runoff, whereas wastewater was produced from human activities.
Furthermore, concerning the weather conditions, sunlight irradi-
ation on Kinmen Island is intense (average annual solar radiation:
757 W/m2), with a long irradiation time (almost 8 h/day during
summer). Therefore, these emerging contaminants may be pho-
todegraded via sunlight photolysis [25e27], which would reduce
their concentrations in the lakewater. However, future elucidation
and investigations are required.
The removal efﬁciencies of each compound in the Jincheng
WWTP are also shown in Table 4. In summary, the removal efﬁ-
ciency of the Jincheng WWTP with regard to the target emerging
contaminants was poor. The primary and secondary treatment
units at the Jincheng WWTP were unable to effectively remove the
target emerging contaminants. Up to 21 and 28 compounds were
less than 50% removal in the primary and secondary treatment
units, respectively. Although 4 compounds (sulfamonomethoxine,
acetaminophen, ibuprofen and caffeine) were effectively removed
(>80% removal) during both sampling periods, 9 compounds
(clarithromycin, nalidixic acid, ﬂumequine, dimetridazole, pro-
pranolol, metoprolol, gemﬁbrozil, carbamazepine and trimetho-
prim) exhibited no any removal. In addition, 15 compounds and 19
compounds were less than 50% removal according to the ﬁrst and
second sampling, respectively.
The performance of the Jincheng WWTP regarding the target
emerging contaminants was similar to the performances of other
WWTPs that also performed secondary treatment processes.
Previously, it has been shown that acetaminophen, ibuprofen and
caffeine are effectively removed in secondary treatment processes
in Taiwan, Austria and Japan [28e31]. Speciﬁcally, it was found in
this study that secondary treatment resulted in >85% removal of
these compounds. Lindqvist et al. [32] investigated ketoprofen
removal in seven sewage treatment plants in Finland and
observed an average removal efﬁciency of 78%, which was slightly
higher than the removal efﬁciency observed in this study. Carba-
mazepine and trimethoprim were persistent throughout the Jin-
cheng WWTP, which corresponded with other studies that also
Table 3
Occurrence of 38 emerging contaminants in the Taihu Lake and Lunghu Lake.
Target compounds MDLs (ng/L) Sampling time
2013/3/6 2013/6/25 2014/6/12
Taihu Lake Lunghu Lake
Sulfonamide antibiotics
Sulfadiazine 0.1 ND ND ND
Sulfamethoxazole 0.1 ND 1.3 ± 0.8 ND
Sulfathiazole 0.5 ND ND ND
Sulfamethazine 0.1 1.5 ± 0.0 2.1 ± 0.2 ND
Sulfamonomethoxine 0.5 ND ND ND
Sulfadimethoxine 0.5 ND ND ND
Macrolides antibiotics
Erythromycin-H2O 0.1 0.9 ± 0.1 3.3 ± 2.8 3.4 ± 1.8
Clarithromycin 0.5 ND 1.1 ± 0.0 0.4 ± 0.6
Roxithromycin 0.5 ND ND ND
Tylosin 1.0 ND ND ND
Quinolone antibiotics
Nalidixic acid 1.0 ND ND ND
Flumequine 0.5 ND 3.0 ± 0.6 ND
Pipemidic acid 1.0 ND ND ND
Norﬂoxacin 1.0 ND ND ND
Ciproﬂoxacin 0.5 ND 5.8 ± 4.4 ND
Oﬂoxacin 0.5 ND 5.1 ± 0.9 1.0 ± 1.8
Imidazole antibiotics
Dimetridazole 0.5 3.4 ± 0.0 5.8 ± 0.2 3.8 ± 0.5
Metronidazole 0.5 ND ND ND
b-blockers
Propranolol 0.6 ND ND ND
Atenolol 1.2 ND ND ND
Metoprolol 0.6 ND ND ND
Sotalol 0.5 ND ND ND
NSAIDs
Acetaminophen 0.1 ND ND ND
Ibuprofen 5 ND 41.7 ± 1.0 11.2 ± 0.5
Naproxen 5 ND 0.3 ± 0.2 ND
Ketoprofen 5 ND 0.8 ± 0.2 ND
Lipid regulator and cholesterol lowering drug
Cloﬁbic acid 0.1 0.4 ± 0.0 ND ND
Gemﬁbrozoil 0.1 ND ND 0.6 ± 0.7
Bezaﬁbrate 0.1 ND ND ND
Psychostimulants
Caffeine 0.1 101.2 ± 2.8 76.8 ± 3.1 ND
Psychiatric drugs
Carbamazepine 0.1 0.4 ± 0.0 0.1 ± 0.1 ND
Vasodilators
Pentoxifylline 0.25 ND ND ND
Other antibiotics
Trimethoprim 0.1 ND ND ND
PFASs
PFOS 0.25 1.3 ± 0.1 ND 5.9 ± 0.3
PFCAs
PFHxA 0.1 32.2 ± 3.2 17.3 ± 3.6 3.2 ± 2.1
PFOA 0.05 11.8 ± 0.7 4.5 ± 0.2 16.8 ± 0.4
PFDA 0.05 0.7 ± 0.2 0.9 ± 0.0 0.7 ± 0.1
PFHpA 0.05 3.5 ± 0.2 3.0 ± 0.4 1.5 ± 0.2
W.W.-P. Lai et al. / Emerging Contaminants 2 (2016) 135e144 139featured biological treatment processes reported in Italy, Spain
and Austria. Particularly, carbamazepine was considered as a
suitable marker for anthropogenic inﬂuences in the aquatic
environment because of its stable characteristics [33e35]. Sec-
ondary treatment processes have a wide range of removal efﬁ-
ciencies with regard to sulfonamide and macrolide antibiotics in
Taiwan, the USA (Wisconsin), Japan and Spain [19,36e38]. This
study also showed large disparities (0e100%) in the removal of
sulfonamides and macrolides. Imidazole antibiotics (dime-
tridazole and metronidazole), lipid regulator and cholesterol-
lowering drugs (cloﬁbric acid, gemﬁbrozil and bezaﬁbrate) and
vasodilators (pentoxifylline) were found to have broad removal
ranges (0e81%) in Taiwan [19]. However, these compounds
exhibited no removal in the JinchengWWTP in this study. In termsof quinolone antibiotics, Jie et al. [39] studied 11 quinolone anti-
biotics in a WWTP in China and showed that their removal efﬁ-
ciencies were between 40 and 75%. In this work, a broad range was
observed (0e82%) in the Jincheng WWTP. Sorption onto sludge
and soil is generally considered a dominant removal mechanism
for quinolones [39,40]. All the investigated PFCs were partially
removed (0e72%), except for the PFOS (100%) in the ﬁrst sampling.
Other various studies reported in Germany, Italy and the USA
(North Carolina) [41e43] have indicated the persistent charac-
teristics of PFCs in municipal wastewaters and surface waters.
Overall, 34 types of emerging contaminant residues existed in the
efﬂuent, of which 11 compounds (sulfamethoxazole, erythro-
mycin-H2O, clarithromycin, tylosin and atenolol) present at con-
centrations greater than 100 ng/L. Many of the compounds,
including erythromycin-H2O, clarithromycin, nalidixic acid, ﬂu-
mequine, dimetridazole, propranolol, metoprolol, gemﬁbrozil,
bezaﬁbrate, carbamazepine, pentoxifylline, trimethoprim and
PFHxA, exhibited increased concentrations in the efﬂuent
compared with the inﬂuent. Similar patterns have been found in
other studies [19,44,45] for erythromycin-H2O, trimethoprim and
propranolol. Some likely explanations for this observation may
include (i) signal suppression because of the high organic matter
concentration in the raw wastewater inﬂuent [46,47], (ii) decon-
jugation of conjugated metabolites during the treatment pro-
cesses [48,49], and (iii) underestimation of the actual quantity due
to the ﬁltering out of particulate matter containing adsorbed
target compounds during the sample ﬁltration pretreatment [50].
Further investigations are needed to verify this phenomenon.
In addition to the Jincheng WWTP, we also collected water
samples from the Taihu WWTP (the second largest WWTP in
Kinmen). Table 5 shows the monitoring results of target com-
pounds in the Taihu WWTP. In general, the occurrence and
removal efﬁciency in the TaihuWWTP were similar to those in the
Jincheng WWTP. Thirty-two compounds were monitored in the
TaihuWWTP inﬂuent and 4 compounds had concentrations at the
mg/L concentration level, including erythromycin-H2O (1340 ng/L),
ibuprofen (1763 ng/L), acetaminophen (2143 ng/L) and caffeine
(3113 ng/L). The other two compounds, ibuprofen (810 ng/L) and
gemﬁbrozil (774 ng/L), also had concentrations nearly at the mg/L
concentration level. With respect to removal efﬁciency, 14 com-
pounds exhibited less than 50% removal, of which 10 compounds
were no any removal. Among all types of target compounds, PFCs
were poorly removed in the Jincheng and Taihu WWTPs.
Because limited information is available regarding the health
risks of these emerging contaminants, the risk quotient (RQ), a
ratio of the measured environmental concentration (MEC) to the
predicted no-effect concentration (PNEC), is commonly used in
preliminary risk assessments for the aquatic environment ac-
cording to the European Medicine Agency guidelines [9,21,51,52].
Table 6 summarizes the PNEC, MECs and RQ values of the PPCPs
detected in the efﬂuent of the Jincheng and Taihu WWTP efﬂuent.
The maximum MECs were used to calculate the RQs as a worst-
case scenario. The reported PNEC values were calculated by
dividing the lowest no observed effect concentration (NOEC) with
an assessment factor. While NOEC data were not available, lowest
observable effect concentrations (LOEC) and critical environ-
mental concentrations (CEC) were used to represent the PNEC. In
Table 6, the PNEC values with one asterisk symbol were calculated
from EC50 [53], and the PNEC values with two asterisk symbols are
the effective concentrations of aquatic ecotoxicity [54]. In this
study, the RQ values of 5 compounds (sulfamethoxazole, eryth-
romycin-H2O, clarithromycin, ciproﬂoxacin and oﬂoxacin) excee-
ded one, which indicated their high environmental impact risks.
The other 9 compounds (norﬂoxacin, acetaminophen, ibuprofen,
naproxen, ketoprofen, gemﬁbrozil, propranolol, carbamazepine,
Table 4
Occurrence and removal of 38 emerging contaminants in the Jincheng WWTP.
Sampling time June 2013 June 2014
Target compounds MDLs (ng/
L)
Occurrence (ng/L) Removal
(%)
Occurrence (ng/L) Removal (%)
Inﬂuent Efﬂuent Overall Inﬂuent Before secondary
treatment
Efﬂuent Primary
treatment
Secondary
treatment
Overall
Sulfonamide antibiotics
Sulfadiazine 0.1 4.6 ± 0.2 1.0 ± 0.2 78% ND ND ND e e e
Sulfamethoxazole 0.1 208.2 ± 34.6 109.2 ± 10.6 48% 414 ± 28.0 423 ± 33.5 237 ± 15.7 NR 44% 43%
Sulfathiazole 0.5 16.3 ± 0.4 ND 100% ND ND ND e e e
Sulfamethazine 0.1 2.9 ± 0.3 1.5 ± 0.1 48% ND ND ND e e e
Sulfamonomethoxine 0.5 19.2 ± 2.9 3.7 ± 0.8 81% 8.8 ± 2.0 7.1 ± 1.2 1.2 ± 1.3 19% 83% 86%
Sulfadimethoxine 0.5 ND ND e 5.3 ± 1.6 1.0 ± 1.4 ND 81% 100% 100%
Macrolides antibiotics
Erythromycin-H2O 0.1 259.5 ± 31.8 298.5 ± 2.1 NR 455 ± 61.3 488 ± 48.6 411 ± 2.5 NR 16% 10%
Clarithromycin 0.5 107.0 ± 9.9 221.0 ± 39.6 NR 282 ± 11.5 274 ± 31.9 311 ± 13.9 3% NR NR
Roxithromycin 0.5 ND ND e 27.8 ± 6.2 1.5 ± 1.8 4.9 ± 0.5 95% NR 82%
Tylosin 1.0 608.0 ± 77.8 139.5 ± 7.8 77% 293 ± 123 136 ± 6.5 151 ± 10.2 54% NR 48%
Quinolone antibiotics
Nalidixic acid 0.25 ND 12.7 ± 0.4 NR ND ND 1.0 ± 0.3 e NR NR
Flumequine 0.5 4.6 ± 0.6 9.8 ± 1.3 NR 19.5 ± 1.7 15.1 ± 1.1 32.7 ± 3.5 23% NR NR
Pipemidic acid 0.5 ND ND e 41.5 ± 11.0 22.7 ± 0.3 24.4 ± 1.1 45% NR 41%
Norﬂoxacin 0.5 72.6 ± 4.8 21.5 ± 1.1 70% 422 ± 51 89 ± 13 77.9 ± 8.0 79% 13% 82%
Ciproﬂoxacin 0.5 34.6 ± 5.7 23.1 ± 4.2 33% 262 ± 56.3 76.7 ± 7.7 75.0 ± 6.0 71% 2% 71%
Oﬂoxacin 0.5 176.7 ± 18.4 78.9 ± 4.3 55% 713 ± 68.9 298 ± 25.0 434 ± 41.9 58% NR 39%
Imidazole antibiotics
Dimetridazole 0.25 3.8 ± 1.3 14.8 ± 0.6 NR 2.9 ± 1.5 4.1 ± 0.7 66.4 ± 9.8 NR NR NR
Metronidazole 0.25 ND ND e 38.2 ± 3.0 36.6 ± 19.7 37.7 ± 1.9 4% NR 1%
b-blockers
Propranolol 0.1 5.3 ± 0.2 6.2 ± 0.5 NR 4.0 ± 0.3 3.7 ± 0.1 4.6 ± 1.0 8% NR NR
Atenolol 0.1 1271.0 ± 1.4 230.0 ± 2.8 82% 1634 ± 118 1107 ± 53.0 653 ± 23.4 32% 41% 60%
Metoprolol 0.1 29.5 ± 3.3 40.3 ± 3.0 NR 5.3 ± 2.0 15.2 ± 3.0 20.0 ± 1.5 NR NR NR
Sotalol 0.5 ND ND e ND ND ND e e e
NSAIDs
Acetaminophen 0.1 1950.0 ± 14.1 2.6 ± 0.3 100% 1887 ± 25.2 676 ± 38.1 104.3 ± 4.9 64% 100% 94%
Ibuprofen 5 1022.5 ± 38.9 60.5 ± 4.8 94% 1260 ± 30.0 619 ± 24.0 189 ± 10.3 51% 69% 85%
Naproxen 5 145.0 ± 1.4 34.1 ± 2.7 76% 685 ± 16.8 225 ± 17.5 257 ± 24.1 67% NR 62%
Ketoprofen 5 7.2 ± 1.1 2.7 ± 0.3 63% 41.0 ± 3.2 26.6 ± 3.7 20 ± 0.8 35% 27% 52%
Lipid regulator and cholesterol lowering drug
Cloﬁbic acid 0.1 ND ND e ND ND ND e e e
Gemﬁbrozoil 0.1 23.0 ± 2.7 46.6 ± 1.8 NR 10.8 ± 0.1 72.8 ± 5.8 106 ± 2.2 NR NR NR
Bezaﬁbrate 0.1 ND ND e ND ND 3.5 ± 0.5 e NR NR
Psychostimulants
Caffeine 0.1 2975.0 ± 205.1 22.2 ± 2.1 99% 2393 ± 115 1156 ± 23.1 176 ± 8.7 52% 85% 93%
Psychiatric drugs
Carbamazepine 0.1 30.8 ± 0.8 52.1 ± 1.7 NR 21.3 ± 2.2 24.2 ± 2.0 50.7 ± 3.9 NR NR NR
Vasodilators
Pentoxifylline 0.25 ND ND e 2.6 ± 0.3 4.3 ± 0.1 6.8 ± 0.4 NR NR NR
Other antibiotics
Trimethoprim 0.1 4.2 ± 0.5 13.8 ± 1.2 NR 19.1 ± 1.9 16.0 ± 1.1 35.0 ± 1.5 16% NR NR
Perﬂuoroalkyl sulfonic acids
PFOS 0.25 2.1 ± 0.0 ND 100% 9.5 ± 1.7 10.7 ± 0.4 5.6 ± 0.1 NR 48% 41%
Perﬂuorinated carboxylic acids
PFHxA 0.1 16.2 ± 0.6 23.7 ± 1.6 NR 24.2 ± 1.0 16.3 ± 2.6 15.6 ± 3.1 33% 4% 43%
PFOA 0.05 6.0 ± 0.1 1.7 ± 0.2 72% 13.1 ± 2.4 13.3 ± 3.1 9.3 ± 0.5 NR 30% 29%
PFDA 0.05 1.1 ± 0.0 0.4 ± 0.1 64% 2.2 ± 0.5 2.5 ± 0.0 1.3 ± 0.1 NR 48% 41%
PFHpA 0.05 1.0 ± 0.2 0.8 ± 0.1 20% 0.3 ± 0.2 0.1 ± 0.1 0.1 ± 0.1 67% NR 67%
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ronmental risk. However, further investigations to understand the
ecological impacts and human health risks of these compounds
are needed. Because these data were acquired during 2013e2015,
periodical monitoring is recommended to ensure the stability of
the reclaimed water quality. The provided data can also be use by
the Kinmen government to establish guidelines, evaluate the
availability of reclaimed water and develop related policies. In
summary, to supply high-quality recycled water and sustainable
water resources, the effectiveness of the WWTPs must beimproved or tertiary/advanced treatment must be added.
4. Conclusions
To evaluate the availability of reclaimed water in Kinmen, this
study investigated the distributions of 38 emerging contaminants
in Kinmen water matrices, including lake waters (Taihu and Lun-
ghu lake) andWWTPwastewaters (Jincheng and TaihuWWTP), by
using SPE combined with high-performance liquid chromatogra-
phyetandem mass spectrometry. The results showed that the
Table 5
Occurrence and removal of 38 emerging contaminants in the Taihu WWTP.
Sampling time July 2015
Target compounds MDLs (ng/L) Occurrence (ng/L) Removal (%)
Inﬂuent Efﬂuent Overall
Sulfonamide antibiotics
Sulfadiazine 0.1 9.2 ± 2.0 3.6 ± 1.2 61
Sulfamethoxazole 0.1 244 ± 37.1 81.6 ± 12.9 66
Sulfathiazole 0.5 ND ND e
Sulfamethazine 0.1 24.7 ± 3.9 6.6 ± 0.9 73
Sulfamonomethoxine 0.5 6.4 ± 2.5 1.4 ± 0.7 78
Sulfadimethoxine 0.5 ND ND e
Macrolides antibiotics
Erythromycin-H2O 0.1 1340 ± 56.9 156 ± 33.6 88
Clarithromycin 0.5 175 ± 37.1 14.3 ± 0.5 92
Roxithromycin 0.5 3.1 ± 1.3 1.2 ± 0.1 60
Tylosin 1.0 ND ND e
Quinolone antibiotics
Nalidixic acid 0.25 79.9 ± 6.4 ND 100
Flumequine 0.5 1.3 ± 0.4 31.6 ± 5.3 NR
Pipemidic acid 0.5 ND ND e
Norﬂoxacin 0.5 72.7 ± 15.8 54.1 ± 16.0 26
Ciproﬂoxacin 0.5 168.9 ± 24.0 19.1 ± 3.7 89
Oﬂoxacin 0.5 345 ± 38.2 195 ± 17.2 43
Imidazole antibiotics
Dimetridazole 0.25 2.8 ± 0.7 54.2 ± 3.8 NR
Metronidazole 0.25 12.1 ± 1.5 49.0 ± 1.4 NR
b-blockers
Propranolol 0.1 ND 0.3 ± 0.2 NR
Atenolol 0.1 196.6 ± 11.1 1.1 ± 0.7 99
Metoprolol 0.1 62.9 ± 6.0 90.7 ± 22.7 NR
Sotalol 0.5 72.9 ± 8.2 17.6 ± 4.8 76
NSAIDs
Acetaminophen 0.1 2143 ± 11.5 ND 100
Ibuprofen 5 1763 ± 277 154 ± 15 91
Naproxen 5 412 ± 12.0 ND 100
Ketoprofen 5 ND ND e
Lipid regulator and cholesterol lowering drug
Cloﬁbic acid 0.1 1.6 ± 0.2 ND 100
Gemﬁbrozoil 0.1 46.7 ± 5.8 15.8 66
Bezaﬁbrate 0.1 22.6 ± 4.3 ND 100
Psychostimulants
Caffeine 0.1 3113 ± 190 ND 100
Psychiatric drugs
Carbamazepine 0.1 83.4 ± 5.6 87.6 ± 2.5 NR
Vasodilators
Pentoxifylline 0.25 264 ± 41.9 62.2 ± 5.0 76
Other antibiotics
Trimethoprim 0.1 1.9 ± 1.0 1.8 ± 0.1 2
Perﬂuoroalkyl sulfonic acids
PFOS 0.25 20.8 ± 4.1 10.6 ± 1.0 49
Perﬂuorinated carboxylic acids
PFHxA 0.1 21.5 ± 1.6 61.4 ± 2.7 NR
PFOA 0.05 23.0 ± 1.4 24.7 ± 1.0 NR
PFDA 0.05 2.6 ± 0.7 3.4 ± 0.4 NR
PFHpA 0.05 2.3 ± 0.7 3.2 ± 0.4 NR
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lakes had reached trace ng/L concentrations. However, many
compounds were detected in the Jincheng and Taihu WWTP. Most
of the target compounds were present in the inﬂuents at ng/L
concentrations, of which 5 compounds (erythromycin-H2O
(1340 ng/L), ibuprofen (1763 ng/L), atenolol (1634 ng/L), acet-
aminophen (2143 ng/L), and caffeine (3113 ng/L)) reached mg/L
concentrations. Further investigations are needed to elucidate the
exact pollution sources. Regarding the removal efﬁciencies, the
results indicated that the overall treatment efﬁciencies of these
emerging contaminants treated by the two WWTPs were poor, as
also indicated in similar studies. For the Jincheng WWTP, although
4 compounds (sulfamonomethoxine, acetaminophen, ibuprofenand caffeine) were >80% removed, 19 compounds were less than
50% removed, and 9 compounds were no any removal at all. Five
compounds (sulfamethoxazole, erythromycin-H2O, clari-
thromycin, ciproﬂoxacin and oﬂoxacin) with RQ values > 1 in the
WWTP efﬂuent are recommended for further investigation to
understand their effects on the aquatic environment. Regular
monitoring of the occurrence and removal of emerging contami-
nants is necessary. To mitigate water scarcity and achieve the goal
of water recycling in Kinmen, the addition of tertiary/advanced
treatment process to the outlets of the Jincheng and Taihu WWTPs
would enhance the efﬁciency of pollutant removal and further
improve the efﬂuent water quality, ensuring the safety of the
reclaimed water for future use.
Table 6
Maximum MECs and risk quotients (RQ) for the PPCPs and PFCs detected in this study (The RQ values which exceed 0.1 are indicated in bold).
Compounds Minimum PNEC (ng/L) Jincheng WWTP efﬂuent Taihu WWTP efﬂuent
Maximum MEC (ng/L) Worst case-scenario (RQ ¼ MEC/PNEC) Maximum MEC (ng/L) Worst case-scenario (RQ ¼ MEC/PNEC)
Sulfonamide antibiotics
Sulfamethoxazole 27a,l 237 8.8 81.6 3.0
Sulfamethazine >100,000b 1.5 0.000015 6.6 0.000066
Sulfadimethoxine 3500c,l ND e ND e
Macrolide antibiotics
Erythromycin-
H2O
20d,l 411 21 156 7.8
Clarithromycin 40e 311 7.8 14.3 0.36
Roxithromycin 150e 4.9 0.03 1.2 0.008
Tylosin 34,000m 151 0.004 ND e
Quinolone antibiotics
Ciproﬂoxacin 20e 75 3.8 19.1 0.96
Norﬂoxacin 150e 77.9 0.5 54.1 0.36
Oﬂoxacin 16a 434 27 195 12.2
Imidazoles antibiotics
Metronidazole 1250e 37.7 0.03 49.0 0.04
NSAIDs
Acetaminophen 1000c,l 104.3 0.10 ND -
Ibuprofen 1650f,l 189 0.11 154 0.09
Naproxen 2620f,l 257 0.10 ND -
Ketoprofen 160g 20 0.13 ND -
Lipid-regulator/cholesterol-lowering drug
Cloﬁbric acid 4200h ND e ND e
Gemﬁbrozil 900c,l 106 0.12 15.8 0.02
Bezaﬁbrate 5300c,l 3.5 0.001 ND e
b-blockers
Propranolol 10a 6.2 0.62 0.3 0.03
Atenolol 30,000d,l 653 0.02 1.1 0.00004
Metoprolol 800c,l 40.3 0.05 90.7 0.11
Psychostimulants
Caffeine 5200g 176 0.03 ND e
Psychiatric drugs
Carbamazepine 250g 52.1 0.21 87.6 0.35
Other antibiotics
Trimethoprim 1000 35 0.04 1.8 0.0018
Perﬂuoroalkyl sulfonic acids
PFOS 50i,j 5.6 0.11 10.6 0.21
Perﬂuorinated carboxylic acids
PFOA 60,000k 9.3 0.0002 24.7 0.0004
a Ref. [57].
b Ref. [60].
c Ref. [59].
d Ref. [61].
e Ref. [55].
f Ref. [58].
g Ref. [62].
h Ref. [56].
i Ref. [63].
j Ref. [64].
k Ref. [65].
l The value is calculated from EC50 (Ref. [53]).
m Effect concentration of aquatic ecotoxicity (Ref. [54]).
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